Skip to content
CoVICIS
  • Home
  • About
    • Our Mission
    • Objectives
    • Consortium
    • Co-funding & Support
  • Scientific Program
    • Population Cohorts
    • Genomic Virological Surveillance
    • Immune Surveillance
    • Data Science
  • Publications
  • News & Resources
    • News
    • Resources
  • Contact
  • Login
CoVICIS
  • Home
  • About
    • Our Mission
    • Objectives
    • Consortium
    • Co-funding & Support
  • Scientific Program
    • Population Cohorts
    • Genomic Virological Surveillance
    • Immune Surveillance
    • Data Science
  • Publications
  • News & Resources
    • News
    • Resources
  • Contact
  • Login
CoVICIS

Author: eurovacc

November 24, 2022November 24, 2022Uncategorized

CoVICIS Newsletter​ November 2022

November 2022 CoVICIS Newsletter CoVICIS so far… Launched in early 2022, CoVICIS […]

Read more
November 11, 2022November 24, 2022Uncategorized

CoVICIS in context: surveillance and South Africa with Prof. Carolyn Williamson, Ph.D., University of Cape Town​

CoVICIS in context: surveillance and South Africa with Prof. Carolyn Williamson, Ph.D., […]

Read more
December 29, 2021December 30, 2021Uncategorized

Our latest press release

date. name of press release Some details. Read press release: English

Read more
November 3, 2021Travel

Similique quis a libero enim quod corporis

Similique quis a libero enim quod corporis saepe quis. Perspiciatis velit quae […]

Read more
January 10, 2013December 30, 2021Uncategorized

Our latest scientific publications

Hosseinipour MC et al.
Phase 1 HIV vaccine trial to evaluate the safety and immunogenicity of HIV subtype C DNA and MF59-adjuvanted subtype C Env protein. Clinical Infectious Diseases. Jan 2020

Read more

Member site menu

  • Agreements
    • Grant Agreements
    • Description of Action
    • Consortium Agreement
  • Consortium Meetings
    • Kick-Off Meeting Part I
      • Agenda & Minutes
      • Presentations
    • Kick-Off Meeting Part 2
      • Agenda & Minutes
      • Presentations
  • Communication Resources
    • Communications Manual
    • Branding materials
  • Technical Documents
  • WG1 Cohorts
    • Agenda & Minutes
    • Updates
  • WG2 Population Surveillance Studies
    • Agenda & Minutes
    • Updates
  • WG3 Virology and Immunology
    • Agenda & Minutes
    • Updates
© 2023 CoVICIS